Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.

The human lympholine osteoclast activating factor (OAF) is thought to be involved in several bone-destroying diseases. The current studies were designed to produce monoclonal antibodies against OAF for use in the subsequent design of immunoassays for OAF in clinical samples. Spleen cells from mice i...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Luben, R A, Mohler, M A, Nedwin, G E
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 1979
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/221547/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109459
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!